Cydectin Triclamox Sheep Drench 5ltr

** NOTE: CALL 01824 703066 TO PLACE YOUR ORDER **


Cydectin Triclamox Sheep Drench 5ltr Cheap Veterinary Drugs Online


167.28 excluding VAT

Clinical trials, after experimental and natural infection, have shown that the product is effective against certain benzimidazole resistant strains of:

Haemonchus contortus

Teladorsagia circumcincta

Trichostrongylus colubriformis

Cooperia curticei

Dosage and administration

For oral use:

Should be given as a single oral drench of 1 ml/5 kg bodyweight, equivalent to 0.2 mg moxidectin/kg bodyweight and 10 mg triclabendazole/kg bodyweight, using any standard drenching equipment.

To ensure a correct dosage, body weight should be determined as accurately as possible accuracy of the dosing device should be checked. If animals are to be treated collectively rather than individually, they should be grouped according to their body weight and dosed accordingly, in order to avoid under or overdosing.

Contraindications, warnings, etc

Do not use in cases of hypersensitivity to the active substance(s) or to any of the excipient(s).

Care should be taken to avoid the following practices because they increase the risk of development of resistance and could ultimately result in ineffective therapy:

Too frequent and repeated use of anthelmintics from the same class, over an extended period of time.

Underdosing, which may be due to underestimation of bodyweight, misadministration of the product, or lack of calibration of the dosing device (if any).

Suspected clinical cases of resistance to anthelmintics should be further investigated using appropriate tests (e.g. Faecal Egg Count Reduction Test). Where the results of the test(s) strongly suggest resistance to a particular anthelmintic, an anthelmintic belonging to another pharmacological class and having a different mode of action should be used.

Resistance to macrocyclic lactones has been reported in Teladorsagia in sheep in a number of countries. In 2008, throughout Europe, moxidectin resistance is very rare it has been reported in a single case involving a levamisole, benzimidazole and ivermectinresistant strain of Teladorsagia circumcincta. Resistance to triclabendazole has been reported in Fasciola hepatica in sheep in some European countries. Therefore the use of this product should be based on local (regional, farm) epidemiological information about susceptibility of parasites, local history of treatments and recommendations on how to use the product under sustainable conditions to limit further selection for resistance to antiparasitic compounds. These precautions are especially important when moxidectin is being used to control resistant strains.

This product should not be used for the treatment of single infections.

In the absence of compatibility studies, this veterinary medicinal product must not be mixed with other veterinary medicinal products.

Signs of overdoses have not been seen at 3 and 5 times the recommended dose. However, if they do occur they should be consistent with the mode of action of moxidectin and/or triclabendazole and would be manifested as transient salivation, depression, drowsiness, ataxia and reduced food intake 8 to 12 hours posttreatment. Treatment is not generally necessary and recovery is generally complete within 1 to 5 days. There is no specific antidote.

This product is safe for use in breeding animals.

Withdrawal period

Meat and offal: 31 days

Milk: not authorised for use in ewes producing milk intended for human consumption including during the dry period. Do not use within 1 year prior to the first lambing in ewes intended to produce milk for human consumption.

Product Choices


Your total price is £

Gwyn Longfield Jones MRCVS reg no M100414X is responsible for the supply of VMP.